| NCT Number | NCT07146412 |
| Lead Sponsor | HudsonAlpha Institute for Biotechnology |
| Conditions | Cognitive Impairment, Alzheimer Blood Biomarkers, Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) |
| Enrollment | 200 participants |
| Start Date | 2025-05-02 |
| Primary Completion | 2026-04-30 (estimated) |
| Study Completion | 2026-04-30 (estimated) |
| Updated on ClinicalTrials.gov | 2025-08-28 |